NewCan Biotech Limited was established in 2021 and is primarily engaged in the research, development, production, and sales of

sugars, nucleosides, nucleotides, phosphorylated monomers, as well as next-generation antiviral and antitumor drug intermediates.

Our products are mainly used in new drug development, biocatalysis, PCR amplification, gene sequencing, diagnostic reagent production, and life science research. We have comprehensive laboratory, analysis, and production facilities equipped with a professional research and development team, enabling us to scale from

small-scale trials and pilot studies to industrial production.

As a leading company in the field, we are committed to providing high-quality raw materials and products to meet the needs of the pharmaceutical, biotechnology,

and life science industries.